DRTS Gunggung Aset Perusahaan Alpha Tau Medical Ltd

Simbol resmi perusahaan Alpha Tau Medical Ltd (DRTS)

The historical price chart of Alpha Tau Medical Ltd. (DRTS) total asset value, reaching 122.59, correlates with the deployment of a B2B partner network across clinics following regulatory approval. Alpha Tau Medical Ltd. (DRTS) develops cutting-edge Alpha DaRT systems for targeted irradiation of neoplasms, investing resources into scientific research. The business model relies on the secure transport of radioactive devices, requiring strict adherence to safety protocols during delivery to medical centers.

DRTS Aset Agregat Perusahaan Alpha Tau Medical (28.04.2023 - 30.10.2026)

Rincian metrik keuangan lan pasar Alpha Tau (DRTS)

- kuotasi saiki lan rata-rata prakiraan nilai:
Bagan bursa alphatau.com|DRTS - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Alpha Tau Corp|DRTS - Nilai Perusahaan
- rincian nilai buku perusahaan:
Aset Bersih saben Saham Alpha Tau Medical|DRTS - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku alphatau.com|DRTS - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Alpha Tau Medical Ltd.|DRTS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Alpha Tau Corp|DRTS - Utang perusahaan|Rasio utang marang kapitalisasi buku Alpha Tau Corp|DRTS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Alpha Tau Medical|Rasio cepet alphatau.com
- data bathi lan kelipatan valuasi:
DRTS - Bathi resik perusahaan
Analisis dhasar perusahaan:alphatau.com, DRTS
Barang utama Alpha Tau Medical

Total assets represent the aggregate volume of company resources, determined inversely through the return on assets (ROA). Analyzing this total asset calculation allows for an assessment of the scale of the asset base relative to generated profits. Stable growth of this metric without excessive debt confirms the financial stability of the business. For Alpha Tau Medical (DRTS), this is critical when deploying expensive radiation therapy infrastructure until a full influx of solvent patients is achieved.

Pesaing utama

NVCR - Gunggung Aset Perusahaan|Aset Agregat Perusahaan Fortress Biotech|Gunggung Aset Perusahaan Acrivon Therapeutics Inc (ACRV)|Total Aset Perusahaan ALLR